Company
United StatesPublic company, NASDAQ: AXGNAxogen Corporation (NASDAQ: AXGN), Burleson, TX – FDA Inspections
Inspection records and compliance data for Axogen Corporation in Burleson, Texas. 5 FDA inspections on record, 1 Form 483, last inspected January 08, 2026. Publicly traded as NASDAQ: AXGN.
Company Profile
This profile covers Axogen Corporation based in Burleson, Texas, United States.
FDA Inspection History
- FDA inspections
- 5
- OAI
- 0
- VAI
- 1
- NAI
- 2
- Unclassified
- 2
- Form 483s
- 1
- Warning letters
- 0
First inspected October 13, 2015. Last inspected January 8, 2026.
Most cited issue areas
- Establishing a system1 inspection
FDA inspections (5)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 8, 2026 | Not classified | Biologics | 1298590 |
| June 19, 2025 | Not classified | Medical Devices & Rad Health | 1275112 |
| July 28, 2022 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1177562 |
| November 20, 2018 | VAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 1072238 |
| October 13, 2015 | NAI | Biologics · Human Cellular, Tissue, and Gene Therapies | 946545 |
FDA documents
EIRs (1)
People (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Axogen Corporation
Stock ticker
AXGN
Exchange
NASDAQ
Share price
$55.40
Market cap
$3.3B
Price as of
November 13, 2026
FEI Number
3011006318
Address
300 Boone Rd Ste A3, Burleson, Texas 76028, United States
Country
United States
ID: c1a3a1ba-57e3-4747-b670-8018198f0309